to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
Landing an angel investment takes a special approach. Learn from the advice of those who've tried and succeeded at lining up angel investors for their healthcare businesses.
The number of healthcare venture deals is at its lowest level in at least five quarters, according to a new report. However, healthcare seed investment hit a record high in the same quarter.
Commercializing a medical device that's clinically superior is not enough in today's economic climate. Medical device companies need to market products that have both clinical and economic value, says the CEO of Medtronic.
In the healthcare business landscape, there's plenty of healthcare investing happening. However, there are still medical problems that could benefit from more investment. Read more about them.
The number of life sciences venture deals was down in the third quarter and first-time funding was down as well. Read more about the reasons behind the numbers.
With medical device companies becoming increasingly frustrated with the U.S. Food and Drug Administration, many American companies are looking to Europe to get approval there first. Here are some tips to consider before pursuing the CE Mark.
Life sciences startups seeking federal funding can benefit from these quick tips. Read more for ideas on where to look and how to go about it.
Venture capital investment in healthcare startups increased last year in the Midwest, but the dollar amount raised lags behind earlier years. Read more about the state of venture capital investing in healthcare startups.
Healthcare investing saw a five-quarter high at the end of 2011, with medical devices getting the largest number of deals. Read more about the state of healthcare venture capital today.
Venture capital investing in health IT is expected to increase, while investing in medical devices and biopharmaceuticals drops, according to a recent National Venture Capital Association survey. Read more about why VCs are favoring health IT companies.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.